The use of march-in rights to target pricy drugs has been a controversial issue across several administrations.

Late January brought Senate confirmation hearings for some of President Donald Trump's most controversial nominees: Kash ...

A new US Government Accountability Office (GAO) report identifies a shortage of public health workers across multiple ...

Donald Trump’s pick for Health and Human Services Secretary could have been using Zyn, young people’s ‘favourite drug’ ...

The Biden administration - in its final weeks - quietly stacked a key health committee in a move that could sabotage Robert F ...

Readers and medical professionals discuss the Trump administration halting communication and travel at HHS. Regarding the Jan ...

After two days of making his case to Senate committees, Robert F. Kennedy Jr.’s bid to lead federal health agencies still ...

Robert F. Kennedy Jr. sounded concern on the GRAS process and claimed GLP-1s are “miracle drugs” but fell short on the drugs being a silver bullet for curing the obesity epidemic in the US.

House Democrats want to know what the Trump administration plans to do after it rescinded a Biden-era executive order to ...

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

RFK Jr.'s second Senate confirmation hearing focused on vaccines, Medicare, diversity, and science. Key Republicans were reticent to show support.

Robert F. Kennedy Jr.'s views on vaccines and his nomination for HHS secretary were questioned again in a second Senate hearing.